A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.
about
Pathogenesis, diagnosis, and treatment of hepatic encephalopathy.Hepatic injury is associated with cell cycle arrest and apoptosis with alteration of cyclin A and D1 in ammonium chloride-induced hyperammonemic ratsAdvances in the evaluation and management of minimal hepatic encephalopathy.Hepatic encephalopathy: early diagnosis in pediatric patients with cirrhosisManagement of covert hepatic encephalopathy.Rifaximin therapy and hepatic encephalopathy: Pros and cons.Oral l-ornithine-l-aspartate in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled trial.Vigilance and wake EEG architecture in simulated hyperammonaemia: a pilot study on the effects of L-Ornithine-L-Aspartate (LOLA) and caffeine.Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits.Randomised clinical trial: L-ornithine-L-aspartate reduces significantly the increase of venous ammonia concentration after TIPSS.l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials.Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled TrialsL-Ornithine L-Aspartate is Effective and Safe for the Treatment of Hepatic Encephalopathy in Cirrhosis
P2860
Q30907818-BB3E91A8-047D-4C4C-AF17-FC6E555FAA20Q36523843-3294BD60-A420-4DD5-B154-AAFA22708BBDQ37798193-B3597EF4-F5EF-4354-ACC2-CD82EC422D9BQ38199095-5080BB14-57AA-4123-AABA-D676ACDB9E6DQ38515281-F69C098B-DB12-4EFD-9C21-902428F3352DQ42324150-F5A57A4B-F432-4C33-A1C9-2567BA2BF879Q45310576-5B3BF74A-7B80-4C6B-8058-EFA54C0E7CA1Q47856026-0CD2700E-3238-4C81-9F4D-339170084336Q48143582-64F4A9DD-C12C-4FC1-9730-0519FA8A52D1Q50643497-A519AB1B-1903-4C36-8F5C-5DF3507AC1F1Q51344453-CCC74150-A730-47D6-9837-41748B4C9934Q57300671-996624FD-525B-4398-9929-CA5D216D3188Q57300691-E8B56651-588B-4A3E-BB78-B50FDD0D76CC
P2860
A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A double-blind, randomized, pl ...... ol in patients with cirrhosis.
@en
A double-blind, randomized, pl ...... ol in patients with cirrhosis.
@nl
type
label
A double-blind, randomized, pl ...... ol in patients with cirrhosis.
@en
A double-blind, randomized, pl ...... ol in patients with cirrhosis.
@nl
prefLabel
A double-blind, randomized, pl ...... ol in patients with cirrhosis.
@en
A double-blind, randomized, pl ...... ol in patients with cirrhosis.
@nl
P2093
P1433
P1476
A double-blind, randomized, pl ...... ol in patients with cirrhosis.
@en
P2093
Alfred Gangl
Christian Mittermaier
Monika Schmid
Peter Ferenci
P304
P356
10.1111/J.1478-3231.2010.02213.X
P577
2010-04-01T00:00:00Z